To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy
Clinical trial NCT07098897 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07098897
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-05-25
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.